VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BKYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BKYIBIO-key International, Inc.
$4.55$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksBKYICash Flow

BIO-key International, Inc. (BKYI) Cash Flow Statement

30Y historyFree accessUpdated daily

Free cash flow remains deeply negative, evidenced by a -147.4% FCF margin in 2025Q4, indicating a structural inability to fund operations through internal cash generation.

BKYI Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations-4.19M-4.66M-2.91M-3.79M-6.23M-8.98M-4.95M-1.85M-1.61M-2.47M-4.45M-15.56M-2.5M-2.68M65.55K-523.11K-312.93K-1.65M129.17K-2.16M-3.55M-4.51M-5.64M-2.86M-2.26M-1.93M-1.72M-2.2M-4.56M-2.65M-683.59K
Operating CF Margin %--76.5%-42.05%-48.92%-88.73%-175.55%-174.5%-81.6%-39.89%-39.12%-149.44%-295.75%-62.48%-135.14%1.71%-14.91%-8.89%-70.2%1%-21.64%-23.37%-31.73%-101.56%-545.15%-1457.5%---1392.69%-1184.94%-571.63%-2136.23%
Operating CF Growth %-147.43%-60.01%23.18%39.1%30.62%-81.38%-167.52%-14.68%34.56%44.56%71.42%-521.68%6.74%-4194.32%112.53%-67.17%81.09%-1381.01%105.98%39.15%21.31%20.04%-97.57%-26.15%-17.61%-11.74%21.67%51.72%-71.75%-288.14%-
Net Income-4.02M-4.59M-4.3M-8.52M-11.91M-5.07M-9.67M-14.59M-6.87M-4.28M-4.19M-1.86M-1.88M-2.58M3.27K-1.9M-649.77K-2.66M184.53K-1.06M-11.08M358.06K-7.24M-3.83M-4.02M-2.28M-3.13M-3.43M-5.95M-2.59M-823.49K
Depreciation & Amortization324.46K351.73K477.53K590.14K546.01K514.07K426.91K1M1.61M1.58M62.64K56.6K68.8K49.58K39.87K42.73K32.82K50.77K854.24K1.46M4.14M5.88M637.12K6.39K031.94K137.3K485.79K633.26K103.62K20.39K
Stock-Based Compensation143.83K146.57K243.25K265.73K387.91K314.71K792.1K947.72K980.22K940.73K427.84K324.12K207.26K81.64K49.84K57.18K46.38K222.1K415.35K657.6K00000000000
Deferred Taxes16.5K16.5K-23K-134.01K-20.43K410K00720K500K-179.09K-37.88K-157.25K-160.45K-426.84K01M1.91M-119.35K-5.49M00000000000
Other Non-Cash Items-655.22K-209.8K-8.04K4.25M5.07M128.68K4.88M8.66M123.17K32.03K167K109.2K-15.31K188.84K49.84K793.93K-1.02M297.51K-474.37K532.88K573.97K-14.87M52.12K1.78M1.05M143.17K576.98K104.59K1.38M148.09K1.84K
Working Capital Changes43.68K-377.55K696.88K-244.07K-299.02K-5.28M-1.38M2.13M1.82M-1.24M-735.53K-14.15M-722.85K-261.37K349.57K480.65K274.04K-1.48M-731.23K1.73M2.81M4.12M903.46K-816.14K707.46K182.93K692.84K637.95K-620.14K-311.2K117.66K
Change in Receivables-752.72K-201.41K880.98K-478.56K-339.38K-672.58K-186.77K829.41K1.34M-1M258.16K-2.72M-341.32K320.76K359.56K-622.25M496.12K-756.76K1.53M748.65K345.05K01.46M00000000
Change in Inventory401.39K520.83K280.44K402.13K106.29K-4.61M98.17K569.71K-51.98K-481.42K-116.78K-336.82K-2.45K-5.19K4.05K1.54K5.16K-1.78K-8.28K6.49K-8.36K20.84K36.26K000094.27K-545.36K-358.7K-100.62K
Change in Payables-39.87K-301.52K-502.99K57.73K239.14K183.61K-600.4K438.02K-17.96K32.39K-691.71K811.24K-193.6K-480.36K243.84K507.03K-159.83K88.03K-33.1K-174.39K-549.04K0-386.31K00000000
Cash from Investing-7.44K-12.01K-13.05K-1K-696.62K-42.02K-2.23M-543.31K-82.46K-226.76K-52.98K-3.36K-18.63K-129.41K03.29M30.6K6.94M618.97K7.16M799.85K1.83M-15.13M-94.76K1.61K-2.63K-12.52K178.53K-31.4K-171.5K-45.93K
Capital Expenditures-7.44K-12.01K-13.05K-1K-82.04K-42.02K-35.57K-30.49K-82.46K-226.76K-52.98K-3.36K-18.63K-129.41K0-56.2K-9.9K-42.78K-38.16K-49.21K-228.35K-214.4K-275.19K-66.54K000-2.44K-31.4K-163.4K-43.28K
CapEx % of Revenue0.11%0.2%0.19%0.01%1.17%0.82%1.25%1.34%2.04%3.6%1.78%0.06%0.47%6.52%-1.6%0.28%1.81%0.3%0.49%1.5%1.51%4.95%12.7%---1.54%8.17%35.2%135.25%
Acquisitions0000-623.58K0-1.9M00000000007M-65.35K7M00-10.93M00000000
Investments-------------------------------
Other Investing0000-614.58M0-295K0-30.4K-60.7K000003.35B40.5M-42.79M10.53K209.99K28.21K1.06M-2.92M-28.21K1.61K-2.63K-12.52K180.97K0-8.1K-2.65K
Cash from Financing3.34M6.91M2.83M1.43M1.9M-218.6K24.09M2.15M1.73M1.92M1.24M19.04M1.34M4.75M-25K-3.74M500K-6.21M0-4.66M1.96M3.16M20.72M3.95M1.77M2.39M1.68M1.06M2.3M6.09M813.44K
Debt Issued (Net)433.65K398.61K1.09M-2.32M2M-250K-989.99K2.51M00000-321.43K-25K-3.61M0-2.16M0-4.66M634.96K2.9M10.15M3.85M1.83M1.37M1.5M150K1.77M-330K188K
Equity Issued (Net)2.94M6.5M1.74M3.73M56.38K36.63K22.17M01.88M2M1.86M19.5M1.59M5.65M000-4M001.51M558.79K11.25M61.66K00183.52K775.04K113.27K6.42M573.5K
Dividends Paid000000000-630.41K-535.1K0000-125.21K0-37.21K00-55.87K0000000000
Share Repurchases00000000000000000-4M0000000000000
Other Financing-28.1K10.08K017.8K-155.14K-5.23K2.91M-361.27K-143.94K550.04K-84.87K-459.1K-253.16K-575.68K00500K000-131.55K-305.05K-678.69K34.03K-64.9K1.02M0134K412.02K051.94K
Net Change in Cash-885.77K2.26M-73.8K-2.12M-5.12M-9.24M16.91M-244.93K35.22K-772.59K-3.26M3.48M-1.18M1.94M40.55K-966.66K217.67K-920.49K748.14K337.61K-795.66K466.6K-56.56K996.04K-498.22K466.14K-52.32K-962.46K-2.29M3.26M83.91K
Free Cash Flow-4.19M-4.67M-2.93M-3.79M-6.31M-9.02M-4.99M-1.88M-1.7M-2.69M-4.5M-15.56M-2.52M-2.81M65.55K-579.32K-322.83K-1.7M91.02K-2.21M-3.78M-4.73M-5.92M-2.92M-2.26M-1.93M-1.72M-2.2M-4.59M-2.82M-726.87K
FCF Margin %-63.21%-76.7%-42.24%-48.93%-89.9%-176.37%-175.75%-82.95%-41.93%-42.71%-151.22%-295.81%-62.95%-141.66%1.71%-16.51%-9.17%-72.01%0.71%-22.13%-24.88%-33.23%-106.51%-557.85%-1457.5%---1394.23%-1193.1%-606.83%-2271.48%
FCF Growth %-3.22%-59.71%22.86%39.88%30.04%-80.93%-165.08%-10.9%37.01%40.17%71.09%-517.22%10.37%-4391.74%111.32%-79.45%80.98%-1965.03%104.12%41.52%20.05%20.14%-102.48%-29.08%-17.61%-11.74%21.75%52%-62.9%-287.51%-
FCF per Share-6.34-7.03-14.21-67.72-144.48-208.38-115.46-190.41-210.39-584.00-1159.74-4073.14-737.95-1059.2328.39-256.22-143.23-808.7249.04-1301.78-2601.38-3139.38-5878.80-5755.29-5913.67-5731.32-6221.38-9176.95-21144.84-13875.37-2550.44
FCF Conversion (FCF/Net Income)1.04x1.02x0.68x0.45x0.52x1.77x0.51x0.13x0.23x0.58x1.06x8.38x1.33x1.04x20.06x0.28x1.02x-0.35x1.08x2.04x0.32x-12.61x0.78x0.75x0.56x0.84x0.55x0.64x0.77x1.02x0.83x
Interest Paid000010.46K0072.82K000000080.29K000000000000000
Taxes Paid000025.68K00000000041.17K12.39K000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and dilution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Remains Fundamentally Disconnected

As reported in financial statements, BKYI's operating cash flow frequently deviates from net income, with the OCF/NI ratio fluctuating wildly, including a 2.17 reading in 2026Q1, which suggests that reported losses are not being mitigated by consistent cash generation from core operations.

The lack of a stable relationship between net income and operating cash flow indicates that accruals and non-cash adjustments are masking the true cash-generative capacity of the business. Investors should monitor this divergence, as it suggests that the company's accounting earnings are not currently reflective of its underlying cash burn reality.

Persistent Free Cash Flow Deficits

According to recent SEC filings, BKYI's free cash flow trajectory remains deeply negative, with the company recording a -147.4% FCF margin in 2025Q4, highlighting a structural inability to fund operations through internal cash generation despite the ongoing transition toward a recurring software revenue model.

The consistent failure to achieve positive free cash flow suggests that the company's current business model is not yet self-sustaining. This trend warrants further investigation into whether the high cost of customer acquisition and corporate overhead will continue to outpace the growth of the PortalGuard platform.

Working Capital Volatility Impairs Liquidity

Based on BKYI's reported figures, working capital changes have been highly erratic, swinging from a $689.3K inflow in 2024Q4 to a $421.2K outflow in 2025Q1, which indicates that the company's cash position is highly sensitive to the timing of collections and project-based payment cycles.

This volatility suggests that the company may be struggling to manage its receivables effectively, particularly regarding large-scale international contracts. Such fluctuations in working capital appear to exacerbate the company's liquidity constraints, making it difficult to predict cash availability on a quarterly basis.

Hidden Cash Outflows and Adjustments

As evidenced by the cash flow statement, BKYI relies on stock-based compensation, which averaged over $50K per quarter, to supplement its cash position, a practice that may obscure the true economic cost of talent retention in a highly competitive identity management market.

While stock-based compensation is a non-cash expense, it represents a real dilution risk for shareholders that is not fully captured in the operating cash flow figures. Analysts should consider this as a potential hidden cost that effectively subsidizes the company's inability to generate sufficient cash from its core business activities.

BKYI — Frequently Asked Questions

Quick answers to the most common questions about buying BKYI stock.

How much cash does BIO-key International, Inc. (BKYI) generate from operations?

BIO-key International, Inc. (BKYI) generated $-4.7M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is BIO-key International, Inc.'s free cash flow?

BIO-key International, Inc. (BKYI) reported negative free cash flow of $4.7M in 2025, indicating capital requirements exceeded cash from operations.

What is BIO-key International, Inc.'s capital expenditure (CapEx)?

BIO-key International, Inc. (BKYI) spent $0.0M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.